Policy / Pricing Makary resigns, with Diamantas named as acting FDA commissioner Pharmaceutical TechnologyThe resignation comes after reports suggested the President was considering firing him.Read full story pharminent May 12, 2026 (Last updated: May 16, 2026) Pharmaceutical Technology The resignation comes after reports suggested the President was considering firing him. Read full story Post navigation Previous: Arvinas, Pfizer find new partner for ‘Protac’ breast cancer drugNext: Isomorphic Labs receives $2.1bn for AI drug development Related Stories Policy / Pricing MFN affecting Swiss medicines access, says Interpharma pharminent August 13, 2026 Policy / Pricing Prior Authorization Metrics Provide New Insights into Insurer Practices, but Gaps Remain pharminent August 13, 2026 Policy / Pricing Trump signs order that nearly halves childhood immunisation coverage pharminent August 11, 2026
